LIPID ANTIOXIDANTS IN ACUTE CENTRAL-NERVOUS-SYSTEM INJURY

被引:120
作者
HALL, ED
机构
[1] CNS Diseases Research, The Upjohn Company, Kalamazoo, MI
关键词
CENTRAL NERVOUS SYSTEM INJURY; LIPID ANTIOXIDANTS;
D O I
10.1016/S0196-0644(05)82745-3
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Oxygen radical-mediated lipid peroxidation increasingly has been suggested to be an important factor in post-traumatic neuronal degeneration. Thus, numerous studies have evaluated the neuroprotective efficacy of pharmacologic agents with lipid antioxidant activity in models of spinal cord and brain injury. The glucocorticoid steroid methylprednisolone has been shown to possess significant antioxidant efficacy, and when administered to animals or human beings in antioxidant doses, it improves chronic neurologic recovery after spinal cord injury. This activity of methylprednisolone is independent of the steroid's glucocorticoid receptor-mediated actions and has been surpassed by the novel antioxidant 21-aminosteroids that have been developed that are devoid of glucocorticoid activity but have greater antioxidant efficacy than methylprednisolone. One of these, tirilazad mesylate (U-74006F), has been shown to be quite effective in animal models of brain and spinal cord injury and is the subject of phase Ill clinical trials. The consistent benefit afforded by antioxidant compounds further supports the concept that lipid peroxidation is an important therapeutic target for acute pharmacologic neuroprotection.
引用
收藏
页码:1022 / 1027
页数:6
相关论文
共 34 条
[1]  
Demopoulos, Flamm, Pietronigro, Et al., Acta Physiol Scand, The free radical pathology and the microcirculation in the major central nervous system disorders, 492, pp. 91-119, (1980)
[2]  
Kontos, Povlishock, Oxygen radicals in brain injury, CNS Trauma, 3, pp. 257-263, (1986)
[3]  
Braughler, Hall, Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation, Free Radic Biol Med, 6, pp. 289-301, (1989)
[4]  
Hall, Braughler, Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation, Free Radic Biol Med, 6, pp. 303-313, (1989)
[5]  
Hall, Braughler, Glucocorticoid mechanisms in spinal cord injury: A review and therapeutic rationale, Surg Neurol, 18, pp. 320-327, (1982)
[6]  
Hall, Neuroprotective pharmacology of methylprednisolone: A review, J Neurosurg, 76, pp. 13-22, (1992)
[7]  
Hoerlein, Redding, Hoff, Et al., Evaluation of naloxone, crocetin, thyrotropin releasing hormone, methylprednisolone, partial myelotomy, and hemilaminectomy in the treatment of acute spinal cord trauma, J Am Animal Hosp Assoc, 21, pp. 67-77, (1984)
[8]  
Young, DeCrescito, Flamm, Et al., Pharmacological therapy of acute spinal cord injury: Studies with high dose methylprednisolone and naloxone, Clin Neurosurg, 34, pp. 675-697, (1988)
[9]  
Green, Kahn, Klose, A comparative study of steroid therapy in acute experimental spinal cord injury, Surg Neurol, 13, pp. 91-97, (1980)
[10]  
Iuzuka, Iwasaki, Yamamoto, Et al., Morphometric assessment of drug effects in experimental spinal cord injury, Journal of Neurosurgery, 65, pp. 92-98, (1986)